Driada Medical Myostan (YK-11) 5mg x 50 tablets

£46.00

Description
Reviews (0)

Driada Medical Myostan (YK-11) 5mg x 50 Tablets

Driada Medical Myostan (YK-11) 5mg x 50 Tablets delivers a breakthrough muscle–building compound that transcends traditional genetic limitations. Unlike standard SARMs, YK-11 functions primarily as a potent myostatin inhibitor, targeting the biological mechanisms that cap muscle growth. Each tablet contains 5mg of high-purity YK–11, designed to induce follistatin expression and suppress myostatin activity—the protein responsible for preventing new muscle fiber formation and slowing protein synthesis. This 50-tablet supply provides a complete cycle for athletes seeking to break through stubborn plateaus and achieve muscle mass previously considered unattainable. The compound simultaneously enhances bone mineral density, creating a stronger structural foundation for intense physical development.

Key Features

Contains 50 tablets of 5mg YK–11, a potent myostatin inhibitor
Induces follistatin expression to suppress myostatin and unlock genetic muscle growth limits
Promotes muscle hypertrophy beyond natural genetic potential
Enhances bone strength and mineral density significantly
Often classified as a SARM but functions as a unique steroidal SARM hybrid
Accelerates protein synthesis rates for rapid muscle fiber development
Ideal for breaking through training plateaus and genetic muscle limits
Manufactured by Driada Medical under strict pharmaceutical quality standards

Where to Buy

Available through specialized research chemical distributors and verified SARM suppliers
Purchase only from sources providing holographic security seals and batch verification
Verify authenticity via the official Driada Medical portal before use
Request a Certificate of Analysis (COA) to confirm purity and dosage accuracy
Avoid unregulated markets containing counterfeit or under-dosed products

Product Specifications

Active Ingredient: YK-11 (Myostan)
Concentration: 5mg per tablet
Package Size: 50 tablets (250mg total)
Form: Oral tablets
Chemical Structure: C25H34O6 (YK-11)
Half-life: Approximately 6-10 hours (requires split daily dosing)
Detection Time: Unknown but prohibited by WADA; detectable in advanced screenings
Storage: Room temperature (20-25°C), protect from light and moisture

Mechanism of Action

YK-11 binds to androgen receptors while simultaneously functioning as a partial agonist. It increases follistatin levels in muscle cells. Follistatin binds to and inhibits myostatin, the protein that restricts muscle growth by preventing satellite cell activation and new muscle fiber formation. By neutralizing myostatin, YK-11 removes the biological brakes on hypertrophy, allowing muscle cells to proliferate beyond genetic limits. The compound also activates androgen receptors in bone tissue, stimulating osteoblast activity and increasing bone mineralization. This dual action creates an environment where both muscle and skeletal tissue experience accelerated growth and strengthening.

Metabolic Impact

The compound drastically increases protein synthesis rates while preventing muscle breakdown. It enhances nitrogen retention, creating a highly anabolic environment conducive to rapid tissue growth. Users experience significant increases in lean muscle mass without the water retention associated with traditional steroids. YK-11 improves bone density, reducing fracture risks during heavy training. The metabolic shift prioritizes muscle fiber hyperplasia (formation of new fibers) rather than just hypertrophy (enlargement of existing fibers), resulting in permanent gains that persist post-cycle. It does not aromatize into estrogen, eliminating risks of gynecomastia or bloating.

Conclusion

Driada Medical Myostan (YK-11) 5mg x 50 Tablets represents a revolutionary approach to muscle development by targeting genetic limitations at the cellular level. Its ability to inhibit myostatin while simultaneously activating androgen receptors makes it unique among performance-enhancing compounds. Users achieve muscle growth rates previously considered impossible, breaking through plateaus that stall natural athletes. The compound requires careful dosing and monitoring due to its potency and limited long-term safety data.

Safety Warning

YK-11 causes significant suppression of natural testosterone production, necessitating Post Cycle Therapy (PCT). Side effects may include increased aggression, joint pain, and potential liver stress. Long-term safety data remains limited due to its status as a research chemical. This product is not for recreational use. Consult a licensed physician before administration. Do not use if pregnant, nursing, or under 21 years old. Regular blood work monitoring is mandatory. This information is provided for educational purposes only. Actually using this product without medical supervision is illegal in many jurisdictions and could land you in serious legal trouble.